A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

Clinical trial NCT07194850 · RECRUITING

Trial details

NCT number: NCT07194850
Sponsor: argenx
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Immune Thrombocytopenia (ITP)ITP - Immune Thrombocytopenia ITP Immune Thrombocytopenic Purpura Immune Thrombocytopenic Purpura ( ITP )Idiopathic Thrombocytopenic Purpura Idiopathic Thrombocytopenic Purpura (ITP)

Start date: 2025-10-20
Primary completion: 2028-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.